A simple mucus test for cancer screening

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2193-2199

  Shamsuddin, Abulkalam M ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Colorectal cancer; Field effect; Gal GalNAc; Tumor marker

Indexed keywords

N ACETYLGALACTOSAMINE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER SCREENING; CARCINOGENESIS; COLON CANCER; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HEALTH CARE COST; HUMAN; LUNG CANCER; MUCUS; NONHUMAN; OCCULT BLOOD; OXIDATION; PANCREAS CANCER; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; COLORECTAL NEOPLASMS; GALACTOSE; HUMANS; MUCINS; OCCULT BLOOD; TUMOR MARKERS, BIOLOGICAL;

EID: 0029814950     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Wingo PA, Tong T and Bolden S: Cancer statistics 1995. Ca 45: 9-30, 1995.
2. Eddy DM: Screening for colorectal cancer. Ann Intern Med 113: 373-384, 1990.
3. Shamsuddin AM: "Diagnostic Assays for Colon Cancer" CRC Press, Boca Raton, FL 1991.
4. Wagner JL, Duffy B, Wadhwa S and Jakubowski L: Costs and effectiveness of colorectal cancer screening in the elderly. Background paper 5, Office of Technology Assessment, U. S. Congress, Washington, D.C., (1990).
5. Allison JE and Feldman F: Cost benefits of Hemoccult screening for colorectal carcinoma. Dig Dis Sci 30: 860-865, 1485.
6. Barry MJ, Mulley AG and Richter JM: The effect of workup strategy on the cost effectiveness of fecal occult blood screening for colorectal cancer. Gastroenterology 93: 301-310, 1987.
7. Miller, AB: Role of early diagnosis and screening: Biomarkers. Cancer Detect Prevent 15: 21-26, 1991.
8. Ahlquist DA: Occult blood screening: Obstacle to effectiveness. Cancer 70: 1259-1265, 1992.
9. Ransohoff DF and Lang CA. Current concepts: Screening for colorectal cancer. N Engl J Med 325: 37-41, 1991.
10. Muto T, Bussey HJR and Morson BC. The evolution of cancer of the colon and rectum. Cancer 36: 2251-2270, 1975.
11. Winawer SJ, Zauber AG, Ho MN. et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329: 1977-1981, 1993.
12. Kozuka S, Nogake M, Ozeki T and Masumori S: Premalignancy of the mucosal polyp in the large intestine. II. Estimation of the periods required for malignant transformation of mucosal polyps. Dis Colon Rect 18: 494-500, 1975.
13. Shamsuddin AM, Kato Y, Kunishima N, Sugano H and Trump BF: Carcinoma in situ in flat mucosa of large intestine, report of a case with significance in strategies for early detection. Cancer 56: 2849-2854, 1985.
14. Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S and Ishikawa E: Early colorectal carcinoma with special reference to its development de novo. Cancer 64: 1138-1469, 1989.
15. Filipe MI and Branfoot AC: Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer 34: 282-290, 1974.
16. Shamsuddin AM: Morphological and histochemical studies of the colonic epithelium of F-344 rats treated with azoxymethane. Doctoral Dissertation, University of Maryland at Baltimore, 1979.
17. Shamsuddin AM and Trump BF: Colonic epithelium. H. In vivo studies of colon carcinogenesis. Light microscopic, histochemical, and ultrastructural studies of histogenesis of azoxymethane-induced colon carcinomas in Fischer 344 rats. J Natl Cancer Inst 66: 389-401, 1981.
18. Shamsuddin AKM and Trump BF: Colon epithelium. III. In vitro studies of colon carcinogenesis in Fischer 344 rats: N- methyl-N′-nitro-N-nitrosoguanidine-induced changes in colon epithelium in explant culture. J Natl Cancer Inst 66: 403-411, 1981.
19. Shamsuddin AKM, Weiss L Phelps PC and Trump BF: Colon epithelium. IV. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon. J Natl Cancer Inst 66: 413-419, 1981.
20. Shamsuddin AKM, Phelps PC and Trump BF: Human large intestinal epithelium: light microscopy, histochemistry and ultrastructure. Hum Pathol 13: 790-803, 1982.
21. James JT, Shamsuddin AM and Trump BF: A comparative study of the morphological and histochemical changes induced in the large intestine of ICR/Ha and C57B1/Ha mice by 1,2-dimethylhydrazine. J Natl Cancer Inst 77: 955-964, 1983.
22. Dawson PA and Filipe MI: An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon. Cancer 37: 2388-2398, 1976.
23. Lotan R, Skutelsky E, Danon D and Sharon N: The purification, composition and specificity of anti-T lectin from peanut (Arachis hypogaea). J Biol Chem 250; 8518-8523, 1975.
24. Boland CR, Montgomery CK and Kim YS: Alterations in human colonic mucin occuring with cellular differentiation and malignant transformation. Proc Natl Acad Sci USA 79; 2051-2055, 1982.
25. Cooper HS: Peanut lectin-binding sites in large bowel carcinoma. Lab Invest 47: 383-390, 1982.
26. Orntoft TF, Ole Mors NP, Eriksen G, Jacobsen NO and Poulsen HS, Comparative immunoperoxidase demonstration of T-antigcns in human colorectal carcinomas and morphologically abnormal mucosa. Cancer Res 45: 447-452, 1985.
27. McKenzie KL, Purnell DM and Shamsuddin AM: Expression of carcinoembryonic antigen. T-antigen and oncogene products as markers of neoplastic and prencoplastic colonic mucosa. Hum Pathol 18: 1282-1286, 1987.
28. Schulte BA and Spicer SS: Light microscopic histochemical detection of sugar residues in secretory glycoproteins of rodent and human tracheal glands with lectin-horseradish peroxidase conjugates and the galactose oxidasc-Schiff sequence. J Histochem Cytochem 31: 391-403, 1983.
29. Elsaycd AM and Shamsuddin AM: Detection of altered glycoconjugatc in preneoplastic and neoplastic human large intestinal epithelium by galactose oxidase-Schiff sequence. Lab Invest 56: 22A, 1987.
30. Shamsuddin AM and Elsayed AM: A test for detection of colorectal cancer. Hum Pathol 19: 7-10, 1988.
31. Shamsuddin AM: Screening test and kit for cancerous and precancerous conditions. U.S. Patent No. 5, 348,860; 1994.
32. Xu HM, Sakamoto K and Shamsuddin AM: Detection of the tumor marker D-galactose-ß-[1→3]-N-acetyl-D-galactosamine in colonic cancer and precancer. Arch Pathol Lab Med 116: 1234-1238, 1992.
33. Shamsuddin AM and Sakamoto K: Carbohydrate tumor marker: basis for a simple test for colorectal cancer. Adv Exp Med Biol 354: 83-99. 1994.
34. Schreiber JB, Knodell RG and Shamsuddin AKM: Utilization of alterations in colonic mucus as a screening lest for detecting colonic neoplasia. Am J Gastroenterol 83: 1058 abstract, 1988.
35. Knodell RG, Hale R, Antos M, Matossian H and Shamsuddin AKM: A new screening test for detection of colon cancer utilizing neoplasia associated alterations in rectal mucus. Gastroenterology 94: A230 abstract, 1988.
36. Mackett III C, Wilson C, Brna T and Kirkham RD: Comparison of a galactose oxidase test to Hemoccult in colorectal cancer screening. Am J Gastroenterol 94: 1190. abstract, 1989.
37. Sakamoto K, Nakano G and Nagamachi Y: A pilot study on the usefulness of a new test for mass screening of colorectal cancer in Japan. Gastroenterol Jpn 25: 432-436, 1990.
38. Tada M, Ohtsuka H, Iso A, Shimizu S, Okamura M, Aoki K and Kawai K: Screening of colorectal cancer by testing rectal mucus for B-D-Gal(1→3)-D-GalNAc (T-antigen). J Kyoto Pref Univ Med 99: 681-685, 1990.
39. Sakamoto K, Muratani M, Ogawa T and Nagamachi Y: Colon cancer screening by a new test: a prospective study of asymptomatic population. Proc Am Assoc Cancer Res 32: 168 abstract, 1991.
40. Vcev A, Pospihalj B, Bozic D, Candrlic I, Vegar A, Pinotic L and Krucaj Z: The galactose oxidase test for detection of colorectal cancer. Exp Clin Gastroenterol 1: 217-220, 1991.
41. Zhou D-Y, Zhang Y, Nai Z, Pam L Zhang B and Zhang W: Screening of colorectal cancer by testing rectal mucus for T-antigen, Chinese J Digestion 11: 261-263, 1991.
42. Sano C, Kumashiro R, Egashira Y, Egashira K, Takeda N, Horinouchi T, Nakamura Y and Inutsuka S: An evaluation of a new mass survey for colorectal cancer using galactose oxidase test. J Jpn Soc Gastrointest Mass Survey 97: 101-104, 1992.
43. Kristal AR, Baker MS, Feld AD, Ylvisaker JT and Morse KA: Evaluation of a test for abnormal rectal mucus for early detection of colon cancer. Cancer Epid Biomarkers Prev 1: 303-307, 1992.
44. Sakamoto K, Muratani M, Ogawa T and Nagamachi Y: Evaluation of a new test for colorectal neoplasms: a prospective study of asymptomatic population. Cancer Biotherapy 8: 49-55, 1993.
45. Zhou D-Y, Feng F, Zhang Y, Lai Z, Zhang W, Li L xu G, Wan T, Pan D, Zhou D, Zhang Y and Li S: Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal cancer screening: Analysis of a check-up of 6480 asymptomatic subjects. Chinese Med J 106: 739-742, 1993.
46. Utilization of Galactose Oxidase Schiff Test for Colorectal Cancer. Proceeding of Chinese Pathology Research Group for Colorectal Cancer. GO-S Team. Fu-Jiang San-Qiang Biochemistry Co, San-Ming City, Fu-Jiang, PR China, February 1992.
47. Sakamoto K: Correspondence re: AR Kristal et al. Evaluation of a test for abnormal rectal mucus for early detection of colon cancer. Cancer Epid Biomarkers Prev 1: 603-608, 1992.
48. Watanabe H, Mouri I, Yamagushi Y, Yamakawa O, Kawakami H, Satomura Y. Ohta H, Motoo Y, Okai T, Fukui M and Sawabu N: The colon mucus test in comparison with the feacl occult blood test in the detection of gastrointestinal disease. Digestive Endoscopy 4: 139-146, 1992.
49. Shamsuddin AM and Beasley WM: Expression of the tumor marker D-galactose ß-[1-3]-N-acetyl-D-galactosamine by premalignant and malignant prostate. Arch Pathol Lab Med 118: 48-51, 1994.
50. Shamsuddin AM, Tyner GT and Yang G-Y: Common expression of the tumor marker D-galactose-ß-[1→3]-N-acetyl-D-galactosamine by different adenocarcinomas: evidence of field effect phenomenon. Cancer Res 55: 149-152, 1995.
51. Shamsuddin AM: Inositol phosphates have novel anticancer function. J Nutr 125: 725S-732S, 1995.
52. Sakamoto K, Venkatraman G and Shamsuddin AM: Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphophate (phytic acid). Careinogenesis 14: 1815-1819, 1993.
53. Yang G-Y and Shamsuddin AM: IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Anticancer Res 15: 2479-2488, 1995.
54. Allison JE, Feldman K and Tekawa IS: Hemoccult screening in detecting colorectal neoplasm: sensificity, specificity and predictive value: Long-term follow-up in a large group practice setting. Ann Intern Med 112: 328-333, 1990.
55. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA Gerstner JB, Pandya K and Ellefson RD: Accuracy of fecal occult blood screening for colorectal neoplasia, a prospective study using Hemoccult and HemoQuant tests. JAMA 269: 1262-1267, 1993.
56. Winchester DP, Sylvester J and Maher ML: Risks and benefits of mass screening for colorectal neoplasia with the stool guaiac test. Ca 33: 333-343, 1983.
57. Lieberman DA: Cost-effectiveness model for colon cancer screening. Gastroenterology 109: 1781-1790, 1995.